Ask AI
Christine Bestvina

Christine Bestvina, MD

Associate Professor
Associate Director of Thoracic Oncology
Department of Medicine
University of Chicago
Chicago, Illinois

Explore Activities by Christine Bestvina

Title
Format
Credit Type
Credits
Conference to Clinic: A Test-Your-Knowledge Challenge of Emerging Next-Generation KRAS G12C-Targeted Therapies in NSCLC 

Content Format:

Video

Credit Type:

AMA

Credits:

1.00
KRAS G12C–Mutated NSCLC: Addressing Unmet Needs and Emerging Therapeutic Insights

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Conference to Clinic: A Test-Your-Knowledge Challenge of Emerging Next-Generation KRAS G12C–Targeted Therapies in NSCLC

Content Format:

Slideset

Credit Type:

--

Credits:

--
Research Focus in KRAS-Mutated NSCLC

Content Format:

Slideset

Credit Type:

--

Credits:

--
Research Focus in Advanced NSCLC: Emerging Insights on Next-Generation KRAS G12C Inhibitors

Content Format:

Text Module

Credit Type:

AMA

Credits:

0.75
Advancing KRAS G12C-Targeted Therapies in NSCLC: Current Evidence and Future Directions  

Content Format:

Podcast

Credit Type:

--

Credits:

--
Experts Discuss Optimal Treatment for ALK-Positive Advanced NSCLC

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Targeted Therapy TALK: Translating the Latest Advances Into Precision Care forALK-Positive Advanced NSCLC

Content Format:

Video

Credit Type:

AAPA | ACPE | AMA | ANCC

Credits:

1.00
Targeted Therapy TALK: Translating the Latest Advances Into Precision Care for ALK-Positive Advanced NSCLC

Content Format:

Video

Credit Type:

AAPA | ACPE | AMA | ANCC

Credits:

1.00
Patient Resource: Understanding Treatment Options for Advanced ALK-Positive NSCLC 

Content Format:

PDF

Credit Type:

--

Credits:

--
Translating the Latest Advances Into Precision Care for Advanced ALK-Positive NSCLC

Content Format:

Slideset

Credit Type:

--

Credits:

--
Identifying and Mitigating Adverse Events Associated With ALK Inhibitors for Advanced ALK-Positive Non-Small-Cell Lung Cancer

Content Format:

PDF

Credit Type:

--

Credits:

--
Managing Advanced ALK-Positive Non-Small-Cell Lung Cancer: Considerations for Community Practitioners

Content Format:

PDF

Credit Type:

--

Credits:

--
Immunotherapy and Beyond in Metastatic NSCLC: Expert Answers to Your Questions

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Immunotherapy and Beyond in Metastatic NSCLC: Where Are We Now and What’s Next?

Content Format:

Video

Credit Type:

AMA

Credits:

1.00
Immune Checkpoint Inhibitor–Based Combinations for Patients With NSCLC and Acquired Resistance to Immunotherapy

Content Format:

Video

Credit Type:

AMA

Credits:

1.00
Immune Checkpoint Inhibitor–Based Combinations for Patients With NSCLC and Acquired Resistance to Immunotherapy

Content Format:

Slideset

Credit Type:

AMA

Credits:

1.00
Rationale for Chemoimmunotherapy in Metastatic NSCLC and Latest Clinical Trial Data

Content Format:

Slideset

Credit Type:

--

Credits:

--